FDA Approves Rextovy, Another OTC Naloxone Nasal Spray for Opioid Overdose
The FDA approved Rextovy, a 4mg naloxone hydrochloride nasal spray available over-the-counter for emergency opioid overdose treatment. This approval expands patient access to naloxone products without requiring a prescription.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day